Leading synthetic biologists have shared hard-won lessons from their decade-long quest to build the world's first synthetic ...

Ph.D. student Ziqi Zhang has built a career blending machine learning with single-cell biology. His work helps scientists study cellular mechanisms that advances disease research and drug development.

Charles River Laboratories International Inc. has announced the second cohort of its Cell & Gene Therapy Incubator Program (CIP).

A cutting-edge therapy using base-edited immune cells is offering a major breakthrough for patients with one of the toughest ...

The FDA on Tuesday approved etuvetidigene autotemcel (Waskyra) as the first cell-based gene therapy for patients 6 months and ...

Aradigm Health, a new benefits platform aimed at easing the financial sting of coverage for cell and gene therapies, has ...

The U.S. Food and Drug Administration has approved Waskyra (etuvetidigene autotemcel), the first cell-based gene therapy for ...

Second FDA designation for SENTI-202 this year, after Orphan Drug Designation, is supported by clinical data showing deep and durable complete remission rates combined with a well-tolerated safety ...

ASH 2025 oral presentation on SENTI-202 in 20 Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) patients (18 response evaluable) shows high ...

New Access, Safety Standards, and Field Expertise Explained Coalinga, United States – December 1, 2025 / Conservative Game ...